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Topical antifungal bigels: Formulation, characterization 
and evaluation
Bigels with antifungal substances, ciclopirox olamine and 
terbinafine hydrochloride, were made of hydrogel (polo-
xamer 407 gel) and oleogel (polyethylene and liquid paraffin 
mixture). Prepared bigels were found physically stable at 
room temperature for six months and at least four months 
at 40 °C. Released amount of drug decreased when oleogel 
concentration in the formulation increased. Release test 
results depended on the insertion place of active substances. 
The amount of released substance was highest when 
ciclopirox olamine was incorporated in both phases in an 
equal quantity, and terbinafine hydrochloride in oleogel or 
in hydrogel. All formulations showed great inhibition of 
Microsporum canis. Thus, bigels with ciclopirox olamine and 
terbinafine hydrochloride are a promising dosage form for 
topical use.
Keywords: bigel, ciclopirox olamine, terbinafine hydro-
chloride, poloxamer 407, antifungal, Microsporum canis
Topical semi-solid formulations are used to treat various skin and systemic diseases. 
They help avoid hepatic first-pass metabolism and serum absorption is minimal; 
furthermore, high drug concentration in skin is achieved by topical administration (1). 
This is important for long-term therapy, for example, therapy of fungal diseases, which can 
be classified into superficial, subcutaneous and systemic mycoses. The most common 
fungal infections are dermatophytoses.
We hypothesized that incorporation of antifungal active substances in a gel and bigel 
could ensure suitable contact of the drug and the skin and its sufficient release. Bigel (oleo-
gel/hydrogel, oleo-hydrogel, biphasic gels) is a semi-solid formulation that consists of two 
phases: hydrogel and oleogel (2). Gels are semi-solid matrices comprising small amounts 
of a solid dispersed in a relatively large amount of a liquid. Gels might provide faster drug 
release compared to creams and ointments, regardless of water solubility of the substance 
(3). Bigels are stable, non-oily systems that combine advantages of hydrogels and oleogels: 
ease of preparation, possible delivery of lipophilic and hydrophilic drugs, absence of sur-
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form distribution of the drug substance on the skin. Bigels differ from emulgels because 
both phases are structured (5) while in emulgels the internal phase is a liquid.
Two widely used drugs were chosen as model substances: ciclopirox olamine (CPO) 
and terbinafine hydrochloride (TFH). Both compounds have broad antifungal activity 
against dermatophytes, yeasts and other nondermatophytes and are used to treat cutaneous 
and subcutaneous mycoses in humans and in veterinary medicine (6).
TFH is an allylamine, squalene epoxidase inhibitor (7). TFH is well tolerated and is 
also administered orally (1). Terbinafine hydrochloride is used in various topical forms: 
cream, gel, solution.
Ciclopirox is a hydroxyl-pyridone derivate. Ciclopirox reduces the activity of metal- 
-dependent enzymes that affect ion transport through membranes (15). CPO has also a 
broad antibacterial and anti-inflammatory activity. Ciclopirox can be a free acid or 
ethanolamine salt. Ciclopirox olamine is used in lacquers, shampoos, solutions, 
suspensions, creams and gels (15). These substances are used in gel formulations, but there 
is no published research on bigel formulations. It is relevant to investigate the suitability 
of bigels to introduce the tested active substances and achieve effective therapeutic effects.
According to some scientific articles, bigels could be unstable at high temperatures 
because of phase separation (2). Hence, it is important to evaluate the influence of tempera-
ture on the formulation stability. The principal objective of this article is to evaluate the 
stability and quality of bigels prepared with different proportions of hydrogel and oleogel 
according to biopharmaceutical tests in vitro, antifungal activity assay, rheological tests.
EXPERIMENTAL
Materials
Ciclopirox olamine and terbinafine hydrochloride were supplied by Chemical Point 
(Germany). Hydroxypropyl cellulose, Mr 100.000 was purchased from Alfa Aesar 
(Germany). Poloxamer 407 was purchased from Fagron (The Netherlands). Ethanol  > 96 % 
was from Spiritus Vilnensis (Lithuania). Oleogel Pionier PLW (mixture of liquid paraffin 
and polyethylene) was received from Hansen & Rosenthal KG (Germany) as a gift sample.
Preparation of bigels
Different gels with CPO and TFH were formulated and evaluated in previous studies 
(9). The highest release was recorded from poloxamer 407 gels. Therefore, studies with 
poloxamer 407 are continued. Poloxamer 407 was mixed with distilled water and kept in 
refrigerator at +4 °C for 12 hours. The required amount of terbinafine hydrochloride/ 
ciclopirox olamine was then dissolved in a cold poloxamer solution or mixed with oleogel. 
The cold solution was then allowed to warm up to room temperature and hydrogel was 
formed (9). Prepared hydrogel was then mixed with oleogel at room temperature until a 
homogenous formulation was obtained (2). Bigel compositions are given in Table I.
Bigels with different amounts of model substances in phases were prepared in order 
to estimate how that influenced the released amount of active substance. Four different 
types of each formulation were prepared: A – active substance in hydrogel, B – amount of 
active substance in the phase was proportional to the amount of the phase in formulation, 
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C – equal amounts of active substance in both phases, D – active substance in oleogel. 
Amounts of TFH/CPO in oleogel and hydrogel are given in Table II.
Before the measurement of rheological properties, the bigels were kept at room tem-
perature for 24 hours.
Structure analysis
The microstructure of bigels was investigated with the aid of an optical microscope 
analysis. Micrographs were obtained using a Motic microscope (Motic Instruments, Inc.) 
equipped with a 100× objective. Computer software Motic images were used.
Rheological measurements
Rheological measurements were performed with a model MCR102 rotational rheo-
meter (Anton Paar, Austria) equipped with a plate-plate geometry (gap 1 mm); temperature 
was controlled with a Peltier system. Rheological properties were assessed at 32 °C. Flow 
curves were done in the range from 0.01 to 100 s–1. The power-law model was adapted. 
Flow behaviour index n and consistency index K were calculated. All tests were repeated 
three times and averaged results are shown.
In vitro release test
An in vitro release study was performed with natural cellulose membranes Cupro-
phan (Medicell International Ltd., UK), mounted in modified Franz type diffusion cells. 
The diffusion area was 1.77 cm2. An infinite dose of the donor phase was placed into the 
diffusion cell. The aqueous receptor medium was stirred using a hotplate magnetic stirrer 
IKAMAG C-MAG HS7 (IKA-Werke GmbH & Co.KG, Germany) maintaining the tempera-
ture at 32 °C. Samples of the receptor solution were collected at 1, 2, 3, 4, 5, 6 hours and 
replaced with the same volume of fresh receptor solution. All samples were analysed with 
a spectrophotometer (Agilent 8453, Australia) at the wavelength of maximum absorption 
of CPO (303 nm), TFH (283 nm).
Antifungal activity study
Tested bigels were studied for their in vitro antifungal activity against Microsporum canis 
using the agar well diffusion technique (9). Liquid sterile Sabouraud dextrose agar with 
chloramphenicol was used for the preparation of cultures and incubation of fungal species. 
M. canis was isolated from cats affected with dermatophytosis and from 7 to 14 day cultures 
were grown on Sabouraud dextrose agar. The prepared dermatophyte inoculi (1.0 × 106 – 5.0 
× 106 spores per mL) were seeded over the surface of clotted SDA plates and allowed to dry. 
One well with a 7-mm diameter was made in each plate. About 0.1 mL of the bigel was 
 delivered into the well using a micropipette. The plates were incubated at 28 °C for 7 days. 
Antifungal activity was evaluated by measuring the zone of inhibition in millimetres.
Stability study
The bigels were stored in climatic chambers over 6 months at 25 °C/60 % RH (relative 
humidity) and 40 °C/75 % RH and were checked at regular intervals for physical instability. 
The rheological, microscopic and organoleptic features were observed. Formulations were 
no longer investigated after phase separation.
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Statistical analysis
All tests were repeated three times. The mean values and standard deviations of the 
results were calculated using IBM SPSS statistics 20 and Microsoft Office Excel 2016 pro-
grams. The significance of differences was evaluated using Student’s t-test. The differ-
ences were statistically significant at p < 0.05.
RESULTS AND DISCUSSION
Structure analysis
In the first part of this research, we evaluated the structure of formulations. Prepared 
bigels were of milky white colour. Micrographs (Fig. 1) showed the presence of droplets. 
The droplets became larger and of irregular shape as the concentration of oleogel in for-
mulations increased. The size of the droplets of Bi-10, Bi-20, Bi-30 and Bi-40 was up to 38, 
67, 80 and 100 µm, respectively. Bigger droplet sizes in Bi-30 and Bi-40 might have resulted 
in phase separation during the accelerated stability study.
Fig. 1. Microstructure of bigels: A – Bi-10, B – Bi-20, C – Bi-30, D – Bi-40. Reference bar corresponds to 
50 µm.




c)                                                                              d)
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Rheological tests
Rheological studies are relevant to quality evaluation of semi-solid preparations and 
allow identifying product viscosity and structure changes with temperature (10). Even if 
there are no visible changes, a rheological test indicates changes in the internal structure and 
predicts the stability of products. A flow curve can be used to determine whether the rheo-
logical behaviour of the formulation is Newtonian or non-Newtonian and indicates product 
quality. Power law or Ostwald de Waele model is the mathematical model that describes 
pseudoplastic or shear-thickening behaviour: τ = Kγn, where τ is shear stress (Pa), K is 
consistency index (Pa sn), γ is shear rate (s–1), n is flow behaviour index (dimensionless). The 
consistency index is relevant for liquid consistency (10). The flow behaviour index represents 
the departure from Newtonian behaviour (n = 1 for Newtonian fluids) and is a measure of 
pseudoplastic (n < 1) or shear- thickening (n > 1) extent of the system (11).
Based on the study results, it can be stated that oleogel affects the structure of bigels. The 
flow curves are shown in Fig. 2. Values of the flow behaviour index were between 0.1 and 0.2. 
As a part of oleogel in formulation is increasing, the flow behaviour index increases (struc-
tures get weaker). There were statistically significant differences (p < 0.05) between the flow 
behaviour indexes of different formulations. Consistency index decreases when the amount 
of oleogel in formulation increases. This result might be due to the flow of the droplets.
In vitro drug release
In biopharmacy, products are evaluated by a release test in vitro. This study allows 
assessing the suitability of the base to relax the substance. The results depend on the na-
ture of the drug and its solubility in the base, viscosity of the pharmaceutical form, and 
acceptor medium (12).
The analysis of release study results demonstrates that the release of drug from semi-
solid vehicles was influenced by various factors: type of substance, amount of oleogel in 
the formulation and drug incorporation in phases (Table III). The results confirmed that 
the excipients have an impact on the release of active substances (13). The released amount 
Fig. 2. Flow curves of bigels (n = 3).
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Bi-10 T 1.0 – 66.8 22.3 9.9
Bi-20 T 1.0 – 59.3 19.8 19.9
Bi-30 T 1.0 – 51.8 17.3 29.9
Bi-40 T 1.0 – 44.3 14.8 39.9
Bi-10 C – 1.0 66.8 22.3 9.9
Bi-20 C – 1.0 59.3 19.8 19.9
Bi-30 C – 1.0 51.8 17.3 29.9
Bi-40 C – 1.0 44.3 14.8 39.9
Table II. The amounts of TFH/CPO in different phases: oleogel and hydrogel (%, m/m)
Formulation A B C D
Bi-10
hydrogel 1.0 0.9 0.5 0.0
oleogel 0.0 0.1 0.5 1.0
Bi-20
hydrogel 1.0 0.8 0.5 0.0
oleogel 0.0 0.2 0.5 1.0
Bi-30
hydrogel 1.0 0.7 0.5 0.0
oleogel 0.0 0.3 0.5 1.0
Bi-40
hydrogel 1.0 0.6 0.5 0.0
oleogel 0.0 0.4 0.5 1.0
Table III. Consistency indices (K) and flow behaviour indices (n = 3, mean ± SD)
Formulation K n R2
Bi-10 291.55 ± 3.76 0.105 ± 0.004 0.77
Bi-20 254.86 ± 11.04 0.138 ± 0.005 0.89
Bi-30 203.33 ± 7.81 0.173 ± 0.008 0.96
Bi-40 187.27 ± 1.76 0.2002 ± 0.002 0.98
of both substances decreased when the concentration of oleogel increased (Bi-10 > Bi-20 > 
Bi-30 > Bi-40) although the viscosity decreased. Typical release curves are shown in Fig. 3. 
It can be stated that oleogel slows the release from bigels and could be used to prolong the 
effect of the medicine (4).
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Results of the release study can be associated with drug properties. TFH is a hydrophobic 
substance with log P 5.9 (14), which slightly dissolves in water. Poloxamer 407 increases TFH 
solubility, though small solid particles might occur in hydrogel. The released amounts of 
TFH from Bi-10 were in the order of B ≈ A > C > D (Fig. 4a). Similar results were obtained in 
other formulations. CPO is sparingly soluble in water and is less lipophilic (log P 2.3 (14)) 
compared to TFH. The amount of CPO released in Bi-10 was in the following descending 
order: C > B > D ≈ A (Fig. 4b). Increased proportion of oleogel significantly reduced the 
 released amount of active substances and the influence of insertion place became insignificant.
Antifungal activity test
The antifungal study was aimed at assessing whether the released amount of drug 
from the semi-solid form was able to induce a biological effect. Antifungal research re-
Fig. 3. Typical release curves of bigels of: a) terbinafine hydrochloride, and b) ciclopirox olamine. 
(Type B is shown in the graph – the amount of active substance is proportional to the amount of the 
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vealed that bases without drug substances had no biological effect against M. canis. All 
formulations showed great inhibition of pathogenic fungi. The zones of inhibition were 
69–71 mm for formulations of ciclopirox and more than 80 mm for terbinafine. The obtained 
results confirm the scientific literature data that a lower concentration of terbinafine 
hydrochloride is required to achieve a biological effect against dermatophytes compared 
to ciclopirox olamine (15). Tested bigels released the required amount of active substances, 
which ensured the effectiveness against M. canis.
Stability study
As the internal structure of the preparation may vary during storage, its rheological 
characteristics were evaluated. The structure became less stable when the consistency 
 index decreased; there was even no visible phase separation. No changes were observed 
Fig. 4. Typical release curves of bigels of: a) terbinafine hydrochloride, and b) ciclopirox olamine (Bi-10 
is shown in the graph) (n = 3). A – active substance in hydrogel, B – the amount of active substance in 
the phase is proportional to the amount of the phase in the formulation, C – equal amounts of active 
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in the organoleptic characteristics over 6 months at 25 °C/60 % RH (Fig. 5). The results 
confirmed the data of scientific literature that bigels are stable at room temperature for 
6–12 months (4).
Table IV. Amount of terbinafine hydrochloride or ciclopirox olamine released in 6 hours (n = 3, mean ± SD)









































































Fig. 5. Stability of blank bigels at 25 °C (n = 3, mean ± SD).
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Some changes were observed in the accelerated stability study. The consistency index 
started to drop and after a while phase separation was observed. Phase separation was 
observed after 4 months for Bi-40 and 5 months for Bi-30 at 40 °C/75 % RH (Fig. 6). Lower 
viscosity and larger droplets could lead to lower stability of Bi-30 and Bi-40.
CONCLUSIONS
In the present study, bigels were successfully developed using the poloxamer 407 gel 
as a hydro phase and oleogel of liquid paraffin and polyethylene as an apolar phase. The 
microstructure of bigels showed the formation of emulsion droplets. Drug release and 
antifungal studies suggested that the tested bigels released a sufficient amount of  ciclopirox 
olamine and terbinafine hydrochloride and were effective against Microsporus canis. The 
rheological test allowed assessing the changes of internal structure and determining the 
stability of the tested formulation. No changes in organoleptic properties were found over 
six months of storage and the structural change did not damage the formulations 
excessively. Results of the study show that the tested bigels are a promising form for 
antifungal substances and further comparative studies are needed.
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